Lausanne, Switzerland · Founded 2024 · Privately Held (backing)
Developer of regenerative therapies designed to restore neural function and address neurodegeneration through engineered cell integration. AzureCell Therapies is based in Lausanne, Switzerland and was founded in 2024. It has raised $1.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$1.3M
Last round
—
Cap table — not yet on record
AzureCell Therapies's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AzureCell Therapies with a free account
·Watch AzureCell Therapies: the Monday email on marks, rounds and moves
